Search Results - Rittoles, Aliusha

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study

    Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study by Venegas-Rodríguez, Rafael, Serrano-Díaz, Anabel, Peña-Ruiz, Ruben, Santana-Sánchez, Raul, Hernández-Cedeño, Mabel, Rittoles Navarro, Aliusha, Grecesqui-Cruz, Inti, Pérez-Aguilera, Liam, Segura-Fernández, Anadys, Rosario-Cruz, Leticia, Martínez-Donato, Gilliam, Guillén-Nieto, Gerardo, Domínguez-Horta, Maria Del Carmen

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial

    Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial by Cruz, Leticia R, Baladrón, Idania, Rittoles, Aliusha, Díaz, Pablo A, Valenzuela, Carmen, Santana, Raúl, Vázquez, Maria M, García, Ariadna, Chacón, Deyli, Thompson, Delvin, Perera, Gustavo, González, Ariel, Reyes, Rafael, Torres, Loida, Pérez, Jesus, Valido, Yania, Rodriguez, Ralysmay, Vázquez-Bloomquist, Dania M, Rosales, Mauro, Ramón, Ailyn C, Pérez, George V, Guillén, Gerardo, Muzio, Verena, Perera, Yasser, Perea, Silvio E

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: